(Prototype team page) |
|||
Line 5: | Line 5: | ||
<div class="column full_size"> | <div class="column full_size"> | ||
− | < | + | <section id="team"> |
− | <p> | + | <div class="container"> |
+ | <div class="row"> | ||
+ | <h2 class="subtitle text-center">Meet The Team</h2> | ||
+ | <div class="col-md-3"> | ||
+ | <div class="team-member wow fadeInLeft animated" data-wow-duration="500ms" data-wow-delay=".3s" style="visibility: visible; animation-duration: 500ms; animation-delay: 0.3s; animation-name: fadeInLeft;"> | ||
+ | <div class="team-img"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/e/e6/T--Edinburgh_OG--filippo.png" class="team-pic" alt=""> | ||
+ | </div> | ||
+ | <h3 class="team_name">Filippo Abbondanza</h3> | ||
+ | <p class="team_designation">MSc Synthetic Biology & Biotechnology</p> | ||
+ | <p class="team_text">Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.</p> | ||
+ | <p class="social-icons"> | ||
+ | <a href="https://www.facebook.com/filippo.abbondanza" class="facebook" target="_blank"><i class="ion-social-facebook-outline"></i></a> | ||
+ | <a href="https://www.linkedin.com/in/filippo-abbondanza-a9130897" target="_blank"><i class="ion-social-linkedin-outline"></i></a> | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-md-3"> | ||
+ | <div class="team-member wow fadeInLeft animated" data-wow-duration="500ms" data-wow-delay=".5s" style="visibility: visible; animation-duration: 500ms; animation-delay: 0.5s; animation-name: fadeInLeft;"> | ||
+ | <div class="team-img"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/8/8e/T--Edinburgh_OG--erin.png" class="team-pic" alt=""> | ||
+ | </div> | ||
+ | <h3 class="team_name">Erin Corbett</h3> | ||
+ | <p class="team_designation">MSc Synthetic Biology & Biotechnology</p> | ||
+ | <p class="team_text">Engineering <i>E. coli</i> to create our mock pathogen testing platform, and engineering the lytic T7 phage.</p> | ||
+ | <p class="social-icons"> | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-md-3"> | ||
+ | <div class="team-member wow fadeInLeft animated" data-wow-duration="500ms" data-wow-delay=".7s" style="visibility: visible; animation-duration: 500ms; animation-delay: 0.7s; animation-name: fadeInLeft;"> | ||
+ | <div class="team-img"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/a/a5/T--Edinburgh_OG--rikki.jpg" class="team-pic" alt=""> | ||
+ | </div> | ||
+ | <h3 class="team_name">Yunqi He</h3> | ||
+ | <p class="team_designation">MSc Biochemistry</p> | ||
+ | <p class="team_text">Engineering the lysogenic P1 phage with a CRISPR system to target resistance gene fragments.</p> | ||
+ | <p class="social-icons"> | ||
+ | <a href="https://www.facebook.com/y.q.heybd" class="facebook" target="_blank"><i class="ion-social-facebook-outline"></i></a> | ||
− | </div> | + | </p> |
− | <div class=" | + | </div> |
+ | </div> | ||
+ | <div class="col-md-3"> | ||
+ | <div class="team-member wow fadeInLeft animated" data-wow-duration="500ms" data-wow-delay=".9s" style="visibility: visible; animation-duration: 500ms; animation-delay: 0.9s; animation-name: fadeInLeft;"> | ||
+ | <div class="team-img"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/3/35/T--Edinburgh_OG--ti.jpg" class="team-pic" alt=""> | ||
+ | <h3 class="team_name">Ti He</h3> | ||
+ | <p class="team_designation">MSc Biotechnology</p> | ||
+ | <p class="team_text">Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.</p> | ||
+ | <p class="social-icons"> | ||
+ | <a href="https://www.facebook.com/profile.php?id=100012772305809" class="facebook" target="_blank"><i class="ion-social-facebook-outline"></i></a> | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="row"> | ||
+ | <div class="col-md-3"> | ||
+ | <div class="team-member wow fadeInLeft animated" data-wow-duration="500ms" data-wow-delay=".3s" style="visibility: visible; animation-duration: 500ms; animation-delay: 0.3s; animation-name: fadeInLeft;"> | ||
+ | <div class="team-img"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/f/fa/T--Edinburgh_OG--lydia.jpg" class="team-pic" alt=""> | ||
+ | </div> | ||
+ | <h3 class="team_name">Lydia Mapstone</h3> | ||
+ | <p class="team_designation">MSc Synthetic Biology & Biotechnology</p> | ||
+ | <p class="team_text">Engineering <i>E. coli</i> to create our mock pathogen testing platform and engineering the lytic T4 phage using BRED.</p> | ||
+ | <p class="social-icons"> | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-md-3"> | ||
+ | <div class="team-member wow fadeInLeft animated" data-wow-duration="500ms" data-wow-delay=".5s" style="visibility: visible; animation-duration: 500ms; animation-delay: 0.5s; animation-name: fadeInLeft;"> | ||
+ | <div class="team-img"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/2/27/T--Edinburgh_OG--yuri.jpg" class="team-pic" alt=""> | ||
+ | </div> | ||
+ | <h3 class="team_name">Yuri Matsueda</h3> | ||
+ | <p class="team_designation">MSc Biotechnology</p> | ||
+ | <p class="team_text">Engineering the lysogenic P1 phage with a CRISPR system to target resistance gene fragments.</p> | ||
+ | <p class="social-icons"> | ||
+ | <a href="https://www.facebook.com/profile.php?id=100004212933551" class="facebook" target="_blank"><i class="ion-social-facebook-outline"></i></a> | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-md-3"> | ||
+ | <div class="team-member wow fadeInLeft animated" data-wow-duration="500ms" data-wow-delay=".7s" style="visibility: visible; animation-duration: 500ms; animation-delay: 0.7s; animation-name: fadeInLeft;"> | ||
+ | <div class="team-img"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/d/d8/T--Edinburgh_OG--anton.jpg" class="team-pic" alt=""> | ||
+ | </div> | ||
+ | <h3 class="team_name">Anton Puzorjov</h3> | ||
+ | <p class="team_designation">MSc Bioinformatics</p> | ||
+ | <p class="team_text">Building a model of bacteria-phage interactions in two-step re-sensitisation combining both lysogenic and lytic phages.</p> | ||
+ | <p class="social-icons"> | ||
+ | <a href="https://www.facebook.com/puzorjov" class="facebook" target="_blank"><i class="ion-social-facebook-outline"></i></a> | ||
+ | <a href="https://twitter.com/AntonPuzorjov" target="_blank"><i class="ion-social-twitter-outline"></i></a> | ||
+ | <a href="https://www.linkedin.com/in/antonpuzorjov/" target="_blank"><i class="ion-social-linkedin-outline"></i></a> | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-md-3"> | ||
+ | <div class="team-member wow fadeInLeft animated" data-wow-duration="500ms" data-wow-delay=".9s" style="visibility: visible; animation-duration: 500ms; animation-delay: 0.9s; animation-name: fadeInLeft;"> | ||
+ | <div class="team-img"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/7/70/T--Edinburgh_OG--yating.jpg" class="team-pic" alt=""> | ||
+ | </div> | ||
+ | <h3 class="team_name">Yating Wang</h3> | ||
+ | <p class="team_designation">MSc Drug Discovery & Translational Biology</p> | ||
+ | <p class="team_text">Engineering the lysogenic phage P1 with a CRISPR system to target resistance gene fragments.</p> | ||
+ | <p class="social-icons"> | ||
+ | <a href="https://www.facebook.com/profile.php?id=100010921308790" class="facebook" target="_blank"><i class="ion-social-facebook-outline"></i></a> | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <br> | ||
+ | <div class="row"> | ||
+ | <div class="col-md-3 col-md-offset-5"> | ||
+ | <div class="team-member wow fadeInLeft animated" data-wow-duration="500ms" data-wow-delay=".3s" style="visibility: visible; animation-duration: 500ms; animation-delay: 0.3s; animation-name: fadeInLeft;"> | ||
+ | <div class="team-img"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/1/1b/T--Edinburgh_OG--owen.jpg" class="team-pic" alt=""> | ||
+ | </div> | ||
+ | <h3 class="team_name">Owen Yeung</h3> | ||
+ | <p class="team_designation">MSc Synthetic Biology & Biotechnology</p> | ||
+ | <p class="team_text">Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.</p> | ||
+ | <p class="social-icons"> | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </section> | ||
<div class="column half_size"> | <div class="column half_size"> |
Revision as of 23:03, 19 October 2017
Meet The Team
Filippo Abbondanza
MSc Synthetic Biology & Biotechnology
Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.
Erin Corbett
MSc Synthetic Biology & Biotechnology
Engineering E. coli to create our mock pathogen testing platform, and engineering the lytic T7 phage.
Yunqi He
MSc Biochemistry
Engineering the lysogenic P1 phage with a CRISPR system to target resistance gene fragments.
Ti He
MSc Biotechnology
Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.
Lydia Mapstone
MSc Synthetic Biology & Biotechnology
Engineering E. coli to create our mock pathogen testing platform and engineering the lytic T4 phage using BRED.
Yuri Matsueda
MSc Biotechnology
Engineering the lysogenic P1 phage with a CRISPR system to target resistance gene fragments.
Anton Puzorjov
MSc Bioinformatics
Building a model of bacteria-phage interactions in two-step re-sensitisation combining both lysogenic and lytic phages.
Yating Wang
MSc Drug Discovery & Translational Biology
Engineering the lysogenic phage P1 with a CRISPR system to target resistance gene fragments.
Owen Yeung
MSc Synthetic Biology & Biotechnology
Engineering the lysogenic lambda phage with a CRISPR system to target resistance gene fragments.
What should this page have?
- Chronological notes of what your team is doing.
- Brief descriptions of daily important events.
- Pictures of your progress.
- Mention who participated in what task.
Inspiration
You can see what others teams have done to organize their notes: